VessConnect Plug Flow innovative technology providing patients a safer more...
VessConnect Plug Flow innovative technology providing patients a safer more effective and less costly procedure for vascular anastomosis
Proposal title*
VessConnect Plug & Flow innovative technology providing every year to 270.000 European patients a safer, more effective and less costly procedure for vascular anastomosis
ACRONYM:
PLUGandFLOW
Free keywords
vas...
ver más
31/05/2018
SURG SOLUTIONS
71K€
Presupuesto del proyecto: 71K€
Líder del proyecto
SURG SOLUTIONS
La investigacion, desarrollo, fabricacion y comercializacion de material quirurgico sanitario o de naturaleza analoga
Descripción del proyecto
Proposal title*
VessConnect Plug & Flow innovative technology providing every year to 270.000 European patients a safer, more effective and less costly procedure for vascular anastomosis
ACRONYM:
PLUGandFLOW
Free keywords
vascular anastomosis, microvascular anastomosis, microsurgery, NiTiNol, advanced materials, bio-absorbable Shape Memory Polymers, Advanced Material Innovation applied to surgical device, microsurgery
Abstract:
Vascular anastomosis, the surgical union of two blood vessels, has been technically performed in the same way for the last 100 years: suturing both ends of the vessels with microsutures. Even though several devices have appeared to ease the proceeding, none of them could improve traditional techniques. The result is a time-consuming procedure, with a long learning curve, which is not widely spread in private health systems because of its dangers and lack of efficiency and reliability.
Surg Solution’s, is a start-up company founded by two surgeons, one bio-medical engineer and a business consultant, that has designed, prototyped and solicited a PCT patent for a device, VessConnect, that will reduce costs and probabilities of failure in anastomosis procedures. The product, a stent-like device, relies on the shape-memory characteristics of NiTiNol.
Vascular anastomosis is a widely spread surgical procedure used in organ transplants and general reconstruction surgery, among others. Vessconnect has the potential to impact on the health improvement of the 270.000 European patients that we estimate need a surgery involving an anastomosis every year. Surg Solution aims to gain with VessConnect, 45% market-share of microvascular anastomosis in top European Markets in 5 years, generating €18M on revenues by 2021 with a 77% EBITDA margin.
VessConnect is at TRL6. We aim to launch the product by mid 2019, bringing to patients a safer surgery, to surgeons an easier procedure and to the healthcare system a more efficient solution to perform vascu
Seleccionando "Aceptar todas las cookies" acepta el uso de cookies para ayudarnos a brindarle una mejor experiencia de usuario y para analizar el uso del sitio web. Al hacer clic en "Ajustar tus preferencias" puede elegir qué cookies permitir. Solo las cookies esenciales son necesarias para el correcto funcionamiento de nuestro sitio web y no se pueden rechazar.
Cookie settings
Nuestro sitio web almacena cuatro tipos de cookies. En cualquier momento puede elegir qué cookies acepta y cuáles rechaza. Puede obtener más información sobre qué son las cookies y qué tipos de cookies almacenamos en nuestra Política de cookies.
Son necesarias por razones técnicas. Sin ellas, este sitio web podría no funcionar correctamente.
Son necesarias para una funcionalidad específica en el sitio web. Sin ellos, algunas características pueden estar deshabilitadas.
Nos permite analizar el uso del sitio web y mejorar la experiencia del visitante.
Nos permite personalizar su experiencia y enviarle contenido y ofertas relevantes, en este sitio web y en otros sitios web.